Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials.
Diener
H C
HC
Department of Neurology, University of Essen, Germany. h.diener@uni-essen.de
Dowson
A J
AJ
Ferrari
M
M
Nappi
G
G
Tfelt-Hansen
P
P
D004311:Double-Blind Method; D004992:Ethics, Medical; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D010080:Oxazoles / Q000627:therapeutic use*; D023303:Oxazolidinones; D010919:Placebos; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use*; D016896:Treatment Outcome; D014363:Tryptamines
D010080:Oxazoles; D023303:Oxazolidinones; D010919:Placebos; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C089750:zolmitriptan; D018170:Sumatriptan